
Spnib (Dasatinib 70 mg) is an oral anticancer medicine used in the treatment of certain blood cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
| Manufacturer | Zydus Cadila |
| Generic Name | Dasatinib |
| Strength | 70 mg |
| Pack size | 60 Tablets |
| Used For | Chronic myeloid leukemia and Acute lymphoblastic leukemia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 Tablets | $140 | £104 | A$195 | ₱8,777 | د.ت407.54 | ₩187,474 | lei 634 | HK$1,098 | RM570 | ฿4,623 | S$177 | د.إ514.22 | ر.س525.70 | ر.ق509.74 | د.ك42.700 |
Dasatinib is a tyrosine kinase inhibitor (TKI) that blocks the abnormal BCR-ABL protein, which drives the uncontrolled growth of leukemia cells. By inhibiting this protein, it stops cancer cell signaling, slowing or preventing disease progression.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.